Primary Biliary Cholangitis

Slides:



Advertisements
Similar presentations
Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis
Advertisements

81 year old, female 81 year old, female diagnosis of primary biliary cirrhosis (PBC) in 2000, at the age of 67, based on: diagnosis of primary biliary.
Banff 2001 Liver Group Discussions. 1. Rejection 2.Centrilobular (zone 3) inflammatory lesions 3.Changes in late post-transplant biopsies Banff
Examples of systematic reviews Goran Poropat. Cochrane systematic reviews To make unmanageable amounts of information – manageable Identify, appraise.
Approach to medical liver biopsies Dr Behrang Mozayani Consultant Histopathologist Southmead hospital Bristol.
Cholestatic liver diseases:
Primary Sclerosing Cholangitis - Clinical Studies - Oslo U. Beuers Academic Medical Center, Univerity of Amsterdam, NL.
IL FEGATO IL PANCREAS…..ed I loro segnali
Primary Sclerosing Cholangitis
Other causes of Cirrhosis: Genetic eg. Wilson's Disease, Hemochromatosis Autoimmune eg. Autoimmune Hepatitis, Primary Biliary Cirrhosis, Primary Sclerosing.
Survival Analysis 1 Always be contented, be grateful, be understanding and be compassionate.
Liver Seminar for Health Plan Case Managers September 23, 2008 October 2, 2008.
BRÍD MCHUGH C DT204/2 R&D ASSIGNMENT Primary Biliary Cirrhosis.
DIAGNOSIS OF WILSON’S DISEASE – A 20-YEAR AUDIT Geetha Rathnayake 1, Mirette Saad 2, Kay Weng Choy 1, James CG Doery 1,3 1 Monash Pathology, Monash Medical.
Where Are We on the Path to Elimination of Chronic Hepatitis C?
Multimodal Management of Opioid-Induced Constipation
Seeking Treatments for PSC Out of the Desert and into the Woods
Applying the New Multiple Sclerosis Guidelines to Clinical Practice
Natural history of pruritus in primary biliary cirrhosis
Role of ERCP in patients with PSC
Clinical outcome after SVR: Veterans Affairs
Additional file 1: Table S1
Talking to Patients About HCV Treatment
Exploring Early Combination Therapy in PAH
The case FOR UDCA in PSC Aparna Goel, MD
Hepatorenal Syndrome.
Advancing Management of Anemia With the Latest Data From ERA-EDTA 2018
Update on the Diagnosis and Management of CTEPH in Latin America
Chronic Hepatitis C Virus Infection
Primary Sclerosing Cholangitis in Children
Starting Strong: Initial Evaluation of the Patient With HCV
Risk Stratification in PAH: What Do the Latest Data Suggest?
A Paradigm Shift in PAH.
Valley Fever (Coccidioidomycosis) Incidence of Valley Fever in the US.
Evaluation of the Patient With HCV Infection
Volume 144, Issue 3, Pages e7 (March 2013)
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
VTE in Cancer.
Primary biliary cirrhosis, AMA negative
Primary Biliary Cholangitis
Angelo Armandi Journal Club 17/09/2018.
European Association for the Study of the Liver  Journal of Hepatology 
Translating the Latest and Greatest Advances in PAH Into Clinical Practice.
Updated Guideline Recommendations for the Definitive Diagnosis of Unexplained Syncope.
Volume 128, Issue 2, Pages (February 2005)
Alcoholic liver disease in intensive care
Biost 513 Discussion Section Week 9
US and European Perspectives on Sinusoidal Obstruction Syndrome
Factor Xa Inhibitors in PAD
When Is Intrathecal Drug Delivery Appropriate?
UK IT Industry Awards – UK Public Sector Project of the Year
Volume 136, Issue 4, Pages (April 2009)
Unmet clinical need in autoimmune liver diseases
Covering the Cover Gastroenterology
Current Controversies and Advances in Hepatorenal Syndrome
Volume 117, Issue 5, Pages (November 1999)
KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease    Kidney International.
Reducing Risk for CV Outcomes
When Is Intrathecal Drug Delivery Appropriate?
Branford S et al. Proc ASH 2013;Abstract 254.
At the Crossroads of Coagulation
Volume 141, Issue 4, Pages (October 2011)
PRESENTER: Quynh vu, pgy-2
Volume 54, Issue 2, Pages (February 2011)
LDLT Amany Saleh Elyamany Assistant professor of Hepatology
Natural history of pruritus in primary biliary cirrhosis
Merging the Art and Science of Managing nOH in Clinical Practice
What's New in PAH?.
Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:  
Presentation transcript:

Primary Biliary Cholangitis

Causes and Markers of PBC

PBC Is a Chronic, Progressive Autoimmune Disease

Clinical Features Vary Among Patients

Managing Pruritus

Assessment and Management of Fatigue

Under the Microscope

AASLD Suggested Diagnostic Algorithm in Suspected PBC

Risk of Liver Failure and Death Increases as PBC Progresses

Observed Survival Without Transplantation in UDCA-Treated Patients With PBC

Serologic Predictors of Prognosis

Long-Term Management of Patients With PBC (AASLD Guidance)

Treatment Guidelines Vary

Response Criteria Models

Biochemical Response Criteria Models

Recent or Updated Response Criteria Models

UK Transplantation Data

Summary

Abbreviations

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.